CBD: Why? Who? What? When?


CBD is a non-psychoactive compound officially known as cannabidiol. After the Food and Drug Administration approved two rare strands of CBD as an anti-seizure remedy in 2018, it has been all the rage across the internet and publications. As studies continue to proliferate the benefits of CBD oil for pain, inflammation and seizures, it’s important we understand what, exactly, CBD is.

CBD was first fully structured in 1940 by doctoral candidate B.R. Baker during an attempt to unequivocally synthesize the compound. It was originally thought to be pharmaceutically inactive until further research found it to have great potential benefits as a medicinal agent.


CBD and THC have many similarities, but they have even more differences. We’re going to dissect these two cannabis-based compounds and find out what separates one from the other.

The main differences, aside from CBD being non-psychoactive as opposed to marijuana’s primary psychoactive outcome, are the side effects.

On the rare occasion that CBD oils produce side effects, they are less present than those produced by THC and are concluded to be the result of the drug-to-drug reaction as opposed to the actual CBD. Meanwhile, THC side effects include an increased appetite, lethargy, red eyes and, in prolonged usage, memory loss. CBD has no such long-term effects making it a true wonder of medicinal and recreational products.

CBD Effects

  • Decreases seizures
  • Anti-inflammatory
  • Reduces anxiety
  • Pain reliever

THC Effects

  • Memory loss
  • Slower reaction times
  • Anti-Inflammatory
  • Increased appetite


Under the Controlled Substances Act, which was enacted by the 91st Congress in 1971, CBD is classified as a Schedule 1 controlled substance due to its connection at the time with marijuana. The Controlled Substances Act created five classifications for drugs based on their “potential for abuse” and whether they are acceptable for medical usage.

Schedule 5 drugs, like Robitussin, offer the lowest potential for abuse and are completely acceptable for medical usage; meanwhile, Schedule 1 drugs are considered to have the highest potential for abuse and federally restricted from being used for medicinal purposes.

It wasn’t until 2016 that the Drug Enforcement Administration added cannabis extracts to the list of official Schedule 1 drugs. Previously, CBD was simply considered part of the “marijuana” designation.

However, there is a silver lining. Due to the industrial hemp designation, which separates items made from hemp (like CBD) from those made from cannabis buds (like marijuana), many CBD products get around the Schedule 1 listing and enjoy business in all 50 states with no interference from federal law enforcers. For this reason, CBD is all but legal in the United States despite the 2016 ruling by the DEA. Head shops and health food stores across the country offer lotions, salves, waters and capsules containing CBD of varying dosages.


In June 2018, the FDA approved the oral usage of CBD as an anti-seizure remedy after extensive research into its many medicinal benefits. In addition, 30 states have completely legalized the usage of CBD products for medical treatment. An additional 16 states have authorized the usage of CBD below a specified concentration of THC for medical therapy.

In just five years, the propagation of legalization campaigns and research led to the approval of CBD as a medical agent. It is just a matter of time before the federal government officially authorizes the usage of CBD. As research continues to conclude the benefits of CBD the prevalence of CBD products will increase and the health of the populace will see the bulk of this result.

Share this post

Share on facebook
Share on twitter